FY26 neurofibromatosis research program
Active Awarded Last action
- Contract number
- HT942726FE058
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $161,818
Award facts
- Contract value 54% obligated
- $297,016.57 Current and potential, with all options
- Completion date 39% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a delivery order to Leidos, Inc. on May 31, 2026, with a ceiling value of $297,016.57 for the FY26 Neurofibromatosis Research Program.
Place of performance is Reston, VA. The order is priced cost plus fixed fee and runs through May 30, 2027.
Quick answers
Who was awarded contract HT942726FE058?
HT942726FE058 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on May 31, 2026.
How much is contract HT942726FE058 worth?
The government has obligated $161,818 on HT942726FE058. Its current value, with exercised options, is $297,017.
Is contract HT942726FE058 an order under another contract?
Yes. HT942726FE058 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942726FE058 competed?
The extent of competition for HT942726FE058 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award